EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 255 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,199,224 | -32.6% | 135,200 | -7.0% | 0.13% | +48.2% |
Q3 2022 | $1,780,000 | -11.5% | 145,400 | -14.5% | 0.08% | -5.6% |
Q2 2022 | $2,011,000 | -37.8% | 170,000 | 0.0% | 0.09% | -24.4% |
Q1 2022 | $3,233,000 | -32.3% | 170,000 | -5.6% | 0.12% | -29.6% |
Q4 2021 | $4,779,000 | -35.4% | 180,000 | 0.0% | 0.17% | -41.5% |
Q3 2021 | $7,394,000 | -23.2% | 180,000 | +5.9% | 0.29% | -20.4% |
Q2 2021 | $9,629,000 | +73.7% | 170,000 | +28.8% | 0.36% | +88.1% |
Q1 2021 | $5,544,000 | +46.4% | 132,000 | +144.4% | 0.19% | +13.5% |
Q4 2020 | $3,786,000 | +285.5% | 54,000 | +54.3% | 0.17% | +314.6% |
Q3 2020 | $982,000 | -5.1% | 35,000 | 0.0% | 0.04% | -28.1% |
Q2 2020 | $1,035,000 | +49.1% | 35,000 | 0.0% | 0.06% | +14.0% |
Q1 2020 | $694,000 | -8.1% | 35,000 | +37.3% | 0.05% | +19.0% |
Q4 2019 | $755,000 | +30.2% | 25,500 | 0.0% | 0.04% | +23.5% |
Q3 2019 | $580,000 | +123.1% | 25,500 | +142.9% | 0.03% | +126.7% |
Q2 2019 | $260,000 | – | 10,500 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |